Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Tham, Doris M ^a,d   Martin McNulty, Baby ^c   Wang, Yi Xin ^c   Da Cunha, Valdeci ^c   Wilson, Dennis W ^b   Athanassious, Christian N ^a   Powers, Andrew F ^a   Sullivan, Mark E ^c   Rutledge, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYER AG   (Germany)

^d NONE   (United States)

Author keywords

Aneurysm; Atherosclerosis; Hypertension; Vascular stiffness

Indexed keywords

ANGIOTENSIN; APOLIPOPROTEIN E; COLLAGEN; ELASTIN; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTENSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR RING; VASODILATATION;

EID: 0036889069     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00295.2002     Document Type: Article

References (48)

1. Barton M, Glodny B, d'Uscio LV, Falk E, Kuehle C, Klainguti M, Haudenschild C, Luscher T, and Vetter W. Lack of atherosclerosis and preserved NO-mediated endothelium-dependent relaxation in the common carotid artery of apo E-deficient mice with advanced aortic atherosclerosis. Circulation 104: II-273, 2001.
2. Bates JN, Baker MT, Guerra R Jr, and Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 42: S157-S165, 1991.
3. Berry CL and Greenwald SE. Effects of hypertension on the static mechanical properties and chemical composition of the rat aorta. Cardiovasc Res 10: 437-451, 1976.
4. Bezie Y, Lacolley P, Laurent S, and Gabella G. Connection of smooth muscle cells to elastic lamellae in aorta of spontaneously hypertensive rats. Hypertension 32: 166-169, 1998.
5. Blacher J, Asmar R, Djane S, London GM, and Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33: 1111-1117, 1999.
6. Bouthier JD, De Luca N, Safar ME, and Simon AC. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 109: 1345-1352, 1985.
7. Boutouyrie P, Glaser C, Moryusef A, Bezie Y, Fabiani JN, Laurent S, and Lacolley P. Associations between viscoelastic properties of large arteries and their extracellular matrix composition in abdominal aortic aneurysms in humans. Therapie 54: 85-91, 1999.
8. Brüel A, Ortoft G, and Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 140: 135-145, 1998.
9. Bruel A and Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis 127: 155-165, 1996.
10. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, and Vanhoutte PM. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126: 219-226, 1999.
11. Cifuentes ME, Rey FE, Carretero OA, and Pagano PJ. Upregulation of p67(phox) and gp91(phox) in aortas from anglotensin II-infused mice. Am J Physiol Heart Circ Physiol 279: H2234-H2240, 2000.
12. Corriu C, Feletou M, Puybasset L, Bea ML, Berdeaux A, and Vanhoutte PM. Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol 32: 944-950, 1998.
13. Daugherty A, Manning MW, and Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612, 2000.
14. Dobrin P. Handbook of Physiology. The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. Bethesda, MD: Am. Physiol. Soc., 1983, sect. 2, vol. III, pt. 1, chapt. 3, p. 65-102.
15. D'Uscio LV, Smith LA, and Katusic ZS. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke 32: 2658-2664, 2001.
16. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AK, Morgan DJ, and Cohn JN. The importance of arterial compliance in cardiovascular drug therapy. J Clin Pharmacol 38: 202-212, 1998.
17. Hartley CJ, Reddy AK, Madala S, Martin-McNulty B, Vergona R, Sullivan ME, Halks-Miller M, Taffet GE, Michael LH, Entman ML, and Wang YX. Hemodynamic changes in apolipoprotein E-knockout mice. Am J Physiol Heart Circ Physiol 279: H2326-H2334, 2000.
18. Hartley CJ, Taffet GE, Michael LH, Pham TT, and Entman ML. Noninvasive determination of pulse-wave velocity in mice. Am J Physiol Heart Circ Physiol 273: H494-H500, 1997.
19. Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, Nussberger J, Waeber B, and Brunner HR. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 20: 1-6, 1992.
20. Hickler RB. Aortic and large artery stiffness: Current methodology and clinical correlations. Clin Cardiol 13: 317-322, 1990.
21. Kowaluk EA, Seth P, and Fung HL. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262: 916-922, 1992.
22. Lajemi M, Gautier S, and Benetos A. Rigidity of large arteries and cardiovascular risk. Epidemiological aspects and genetic determinants. Pathol Biol (Paris) 47: 614-622, 1999.
23. Laurent S. Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension 26: 355-362, 1995.
24. Laurent S, Girerd X, Mourad JJ, Lacolley P, Beck L, Boutouyrie P, Mignot JP, and Safar M. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb 14: 1223-1231, 1994.
25. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
26. Levy BI, el Fertak L, Pieddeloup C, Barouki F, and Safar ME. Role of endothelium in the mechanical response of the carotid arterial wall to calcium blockade in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 11: 57-63, 1993.
27. McVeigh GE, Finkelstein SM, and Cohn JN. Assessment of arterial compliance in hypertension. Curr Opin Nephrol Hypertens 2: 82-86, 1993.
28. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B, and Levy BI. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol Regul Integr Comp Physiol 267: R124-R135, 1994.
29. Nakane H, Miller FJ Jr, Faraci FM, Toyoda K, and Heistad DD. Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 35: 595-601, 2000.
30. Nakashima Y, Plump AS, Raines EW, Breslow JL, and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140, 1994.
31. Nakashima Y, Raines EW, Plump AS, Breslow JL, and Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18: 842-851, 1998.
32. Oxlund H. Changes in the biomechanical properties of skin and aorta induced by corticotrophin treatment. Acta Endocrinol 94: 132-137, 1980.
33. Oxlund H and Andreassen TT. The roles of hyaluronic acid, collagen and elastin in the mechanical properties of connective tissues. J Anat 131: 611-620, 1980.
34. Oxlund H, Rasmussen LM, Andreassen TT, and Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 748-752, 1989.
35. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
36. Reddick RL, Zhang SH, and Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14: 141-147, 1994.
37. Safar ME, Peronneau PA, Levenson JA, Toto-Moukouo JA, and Simon AC. Pulsed Doppler: Diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension. Circulation 63: 393-400, 1981.
38. Sherebrin MH, Bernans HA, and Roach MR. Extensibility changes of calcified soft tissue strips from human aorta. Can J Physiol Pharmacol 65: 1878-1883, 1987.
39. Sims TJ, Rasmussen LM, Oxlund H, and Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39: 946-951, 1996.
40. Stegemann H and Stalder K. Determination of hydroxyproline. Clin Chim Acta 18: 267-273, 1967.
41. Symons JD, Mullick AE, Ensunsa JL, Ma AA, and Rutledge JC. Hyperhomocysteinemia evoked by folate depletion: Effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol 22: 772-780, 2002.
42. Tse J, Martin-McNaulty B, Halks-Miller M, Kauser K, DelVecchio V, Vergona R, Sullivan ME, and Rubanyi GM. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 β-estradiol. Atherosclerosis 144: 303-313, 1999.
43. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, and Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88: 947-953, 2001.
44. Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, Mallari C, Martin-McNulty B, da Cunha V, Freay A, Rubanyi GM, and Kauser K. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 278: H428-H434, 2000.
45. Wang YX, Martin-McNulty B, Freay AD, Sukovich DA, Halks-Miller M, Li WW, Vergona R, Sullivan ME, Morser J, Dole WP, and Deng GG. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159: 1455-1464, 2001.
46. Wang YX, Martin-McNulty B, Huw LY, da Cunha V, Post J, Hinchman J, Vergona R, Sullivan ME, Dole W, and Kauser K. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. Atherosclerosis 162: 23-31, 2002.
47. Weiss D, Sorescu D, and Taylor WR. Angiotensin II and atherosclerosis. Am J Cardiol 87: 25C-32C, 2001.
48. Wuyts FL, Vanhuyse VJ, Langewouters GJ, Decraemer WF, Raman ER, and Buyle S. Elastic properties of human aortas in relation to age and atherosclerosis: A structural model. Phys Med Biol 40: 1577-1597, 1995.